View in EDS HTML Full Text PDF Full Text

A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma.

Saved in:
Bibliographic Details
Title: A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma.
Authors: Li HK; Acepodia Biotech Inc., Alameda, CA 94502, USA., Wu TS; Acepodia Biotech Inc., Alameda, CA 94502, USA., Kuo YC; Acepodia Biotech Inc., Alameda, CA 94502, USA., Hsiao CW; Acepodia Biotech Inc., Alameda, CA 94502, USA., Yang HP; Acepodia Biotech Inc., Alameda, CA 94502, USA., Lee CY; Acepodia Biotech Inc., Alameda, CA 94502, USA., Leng PJ; Acepodia Biotech Inc., Alameda, CA 94502, USA., Chiang YJ; Acepodia Biotech Inc., Alameda, CA 94502, USA., Cheng ZF; Acepodia Biotech Inc., Alameda, CA 94502, USA., Yang SH; Acepodia Biotech Inc., Alameda, CA 94502, USA., Lin YL; Acepodia Biotech Inc., Alameda, CA 94502, USA., Chen LY; Institute of Chemistry, Academia Sinica, Taipei 11529, Taiwan.; Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan., Chen CS; Institute of Chemistry, Academia Sinica, Taipei 11529, Taiwan.; Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan., Chen YJ; Institute of Chemistry, Academia Sinica, Taipei 11529, Taiwan.; Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan., Hsiao SC; Acepodia Biotech Inc., Alameda, CA 94502, USA., Tang SW; Acepodia Biotech Inc., Alameda, CA 94502, USA.
Source: Cancers [Cancers (Basel)] 2023 Oct 04; Vol. 15 (19). Date of Electronic Publication: 2023 Oct 04.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers15194844